European Archives - Page 511 of 1056 - European Medical Journal

A Rare Finding: A Left Atrial Cavernous Haemangioma

Cardiac cavernous haemangiomas are rare benign tumours more commonly seen in the right heart; this case demonstrated a LAA cavernous haemangioma, which was unusual.

Rare Right Ventricular Obstructing Myxoma: An Incidental Finding for a Common Symptom

Primary intracardiac tumours are very rare, with an incidence of 0.02% of which myxomas are the most common.1,2 Commonly affecting the mid-aged female population, myxomas are typically located within the atrium (93%) and rarely within the ventricular systems (6–8%).

EuroPCR 2021 Interview: Prof William Wijns

EuroPCR 2021 Interview: Prof William Wijns

Prof William Wijns |PCR Chairman; SFI Professor of Interventional Cardiology, National University of Ireland Galway, Galway, Ireland

EuroPCR 2021 Interview: Prof Bernard Prendergast

EuroPCR 2021 Interview: Prof Bernard Prendergast

Prof Bernard Prendergast | Course Director of PCR London Valves and Co-ordinator for Valves and Structural Activities at PCR; Professor of Interventional Cardiology and Valvular Heart Disease, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

EMJ Interventional Cardiology 9.1 2021 Feature Image

Fractional Flow Reserve, Quantitative Flow Ratio, and Instantaneous Wave-Free Ratio: Comparison of Ionising Radiation Dose

The development of interventional cardiology is inevitably associated with increased dose of ionising radiation for the physician.1 Additionally, physiology-guided myocardial revascularisation is supported by both European and American experts,2,3 but these procedures may increase the total procedure time in addition to increased dose of ionising radiation for the physician.

Fatal Cardiovascular Collapse During Transcatheter Aortic Valve Replacement Due to Valve Migration

Transcatheter valve embolisation and migration (TVEM) into the left ventricle (LV) is especially significant and requires conversion to an emergency surgical technique, with unusually high mortality reported.

Clarity on Cannabinoid-Based Products in Medicine

This document aims to provide an overview of the clinical and regulatory challenges faced in the use of cannabinoid-based products in medicine, without becoming a comprehensive humanity review of the literature on the medical possibilities of cannabinoids.

EMJ Oncology 9 [Supplement 4] 2021 Feature Image

EMJ Oncology 9 [Supplement 4] 2021

OVARIAN cancer is the seventh most commonly diagnosed malignancy among women worldwide, and the gynaecologic cancer with the…

EMJ Oncology 9 [Supplement 4] 2021 Feature Image

PARP Inhibitors in Advanced Ovarian Cancer: A Review of Long-term Efficacy and Survival Rates

This article discusses the results published in 2020 and early 2021 from key clinical trials of PARP inhibitors in patients with advanced ovarian cancer in terms of long-term efficacy and survival rates.

Talking to Denise Dewar

Denise Dewar, Digital Hub Director, Europe, Japan and Canada, GSK, discusses digital transformation and swapping whisky for pharma.